EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Pregnancies in women with cystic fibrosis in the era of CFTR modulators: Current challenges and future perspectives. Insights from the Italian cystic fibrosis registry

Marco Salvatore, Giuseppe Campagna, Annalisa Amato, Daniela Pierannunzio, Pietro Ripani, Giovanni Taccetti, Benedetta Fabrizzi, Fabio Majo, Rita Padoan

Journal of Cystic Fibrosis · 2026

DOI: 10.1016/j.jcf.2025.12.002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cystic Fibrosis, 2026. Verfasst von Marco Salvatore und 8 weiteren Autor:innen. Beteiligte Einrichtung: Undiagnosed Rare Diseases Interdepartmental Unit, National Center Rare Diseases, Istituto Superiore di Sanità, Rome, Italy. Electronic address: marco…. Hauptthemen laut MEDLINE: Cystic Fibrosis, Cystic Fibrosis Transmembrane Conductance Regulator, Pregnancy Complications. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The prognosis for people with Cystic Fibrosis (CF) has significantly improved due to the introduction of CF Transmembrane Regulator (CFTR) modulators. This study aims to analyze pregnancies and related outcomes in Italian women with CF while also identifying current and potential future challenges. METHODS: This retrospective study utilized data from the Italian cystic fibrosis Registry (ICFR), focusing on pregnancies occurring between 2016 and 2023. Key clinical variables assessed included genotype, age at conception, body mass index, percent predicted forced respiratory volume (ppFEV₁), presence of CF-related diabetes (CFRD), and CFTR modulator therapy. The outcomes analyzed were pulmonary function and BMI as a surrogate of nutritional status before and after pregnancy, as well as preterm birth rate, birthweight, and mode of delivery. RESULTS: Between 2016 and 2023, the ICFR reported 172 pregnancies, of which 148 (86.0 %) were carried to term. The median age at conception was 31.8 years (range: 17.0-43.9), median BMI 21.6 kg/m² (range: 16.5-38.9), and median ppFEV₁ 79.7 (range: 29.0-120.4). CFRD was present in 32 women (21.6 %), and 55 (37.2 %) were receiving CFTR modulator therapy. Better clinical status at the beginning of pregnancy was observed in 2016-23 period, with a higher mean ppFEV1, in the mean age at conception and in the mean BMI value. In the present study, only a limited number of women were in severe clinical condition (

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cystic FibrosisCystic Fibrosis Transmembrane Conductance RegulatorPregnancy ComplicationsHumansFemalePregnancyItalyRegistriesAdultRetrospective StudiesPregnancy OutcomeAdolescentYoung Adult

Stichwörter der Autor:innen

CFRDCFTR modulatorsCystic fibrosisPregnancyRegistry

Substanzen

Cystic Fibrosis Transmembrane Conductance Regulator

Autor:innen und Institutionen

  • Undiagnosed Rare Diseases Interdepartmental Unit, National Center Rare Diseases, Istituto Superiore di Sanità, Rome, Italy. Electronic address: marco.salvatore@iss.it.
  • Italian cystic fibrosis Patients League ONLUS-LIFC, Rome, Italy; Department of Medical-Surgical Sciences and Translational Medicine, Faculty of Medicine and Psychology, La Sapienza University, Rome, Italy. Electronic ad…
  • Italian cystic fibrosis Patients League ONLUS-LIFC, Rome, Italy. Electronic address: info@registroitalianofibrosicistica.it.
  • National Center for Disease Prevention and Health Promotion, National Institute of Health, Rome, Italy. Electronic address: daniela.pierannunzio@iss.it.
  • UOSD CRR Fibrosi Cistica Regione Abruzzo Asl Teramo P.O. San Liberatore, Atri, Italy. Electronic address: pietroripani@gmail.com.
  • Meyer Children's Hospital IRCCS, Cystic Fibrosis Regional Reference Centre, Firenze, Italy. Electronic address: giovanni.taccetti@meyer.it.

Zitieren

APA

Salvatore, M., Campagna, G., Amato, A., Pierannunzio, D., Ripani, P., Taccetti, G., Fabrizzi, B., Majo, F., & Padoan, R. (2026). Pregnancies in women with cystic fibrosis in the era of CFTR modulators: Current challenges and future perspectives. Insights from the Italian cystic fibrosis registry. Journal of Cystic Fibrosis. https://doi.org/10.1016/j.jcf.2025.12.002

Vancouver

Salvatore M, Campagna G, Amato A, Pierannunzio D, Ripani P, Taccetti G, et al. Pregnancies in women with cystic fibrosis in the era of CFTR modulators: Current challenges and future perspectives. Insights from the Italian cystic fibrosis registry. Journal of Cystic Fibrosis. 2026. doi:10.1016/j.jcf.2025.12.002

BibTeX
@article{Salvatore2026,
  author = {Salvatore, Marco and Campagna, Giuseppe and Amato, Annalisa and Pierannunzio, Daniela and Ripani, Pietro and Taccetti, Giovanni and Fabrizzi, Benedetta and Majo, Fabio and Padoan, Rita},
  title = {Pregnancies in women with cystic fibrosis in the era of CFTR modulators: Current challenges and future perspectives. Insights from the Italian cystic fibrosis registry},
  journal = {Journal of Cystic Fibrosis},
  year = {2026},
  doi = {10.1016/j.jcf.2025.12.002}
}
Kostenlos starten →